...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >High Expression of c-Met, PKC lambda and ALDH1A3 Predicts a Poor Prognosis in Late- stage Breast Cancer
【24h】

High Expression of c-Met, PKC lambda and ALDH1A3 Predicts a Poor Prognosis in Late- stage Breast Cancer

机译:C-Met的高表达,PKC Lambda和Aldh1a3预测晚期乳腺癌预后差

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aim: Co-expression of c-Met and ALDH1A3 indicates a poor prognosis in stage III-IV breast cancers and contributes to cell proliferation and tumor formation by ALDH1-positive breast CSCs. PKC lambda is overexpressed and contributes to a poor prognosis in several cancers. Materials and Methods: A breast cancer genomics data set (METABRIC, n=2509) was downloaded and analyzed, as was the effect c-Met and PKC lambda inhibitors on ALDH1(high) cell viability and tumor-sphere formation. Results: c-Met expression correlates with expression of PKC lambda in breast cancer. Stage III-IV breast cancer patients with c-Met(high) PKC lambda(high) ALDH1A3(high) have a poorer prognosis than patients with c-Met(low) PKC lambda(low) ALDH1A3(low). Foretinib and auranofin suppressed cell viability and tumor-sphere formation by ALDH1(high) cells. These results suggest that c-Met and PKC lambda are cooperatively involved in cancer progression and contribute to poor prognoses in breast cancer. Conclusion: c-Met and PKC lambda are potentially useful prognostic markers and therapeutic targets in late-stage breast cancer.
机译:背景/目的:C-Met和Aldh1a3的共表达表明III-IV阶段乳腺癌预后差,有助于通过Aldh1阳性乳腺CSC的细胞增殖和肿瘤形成。 PKC Lambda已经过表达,有助于几种癌症的预后差。材料和方法:下载并分析乳腺癌基因组学数据集(元质,N = 2509),如Aldh1(高)细胞活力和肿瘤 - 球形形成的效果C-Met和PKCλ抑制剂。结果:C-Met表达与乳腺癌中PKCλ的表达相关。 III-IV阶段乳腺癌患者C-Met(高)PKCλ(高)Aldh1a3(高)的预后较差,而不是C-Met(低)PKCλ(低)Aldh1a3(低)的患者。 Foretinib和Auranofin抑制细胞活力和通过Aldh1(高)细胞形成的肿瘤球形形成。这些结果表明,C-Met和PKC Lambda合作涉及癌症进展,并对乳腺癌的贫困预期有助于差。结论:C-Met和PKC Lambda可能是晚期乳腺癌中有用的预后标志物和治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号